Anti-LGR4, Humanized Antibody | A2296

LGR4 is a G-protein coupled receptor that binds R-spondins and activates the Wnt signaling pathway, which is necessary for the proper development of many organs in the body. Diseases associated with LGR4 include osteoporosis, and LGR4 has been implicated in tumor progression in many cancer types. This research-grade biosimilar is a humanized antibody that targets the human LGR4 receptor.

A2296 | Anti-LGR4, Humanized Antibody DataSheet

Antibody Target: Human LGR4

Target Alternative Name: Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 4; Leucine Rich Repeat Containing G Protein Coupled Receptor 4; G Protein-Coupled Receptor 48; GPR48; BNMD17

Tag Line: A humanized monoclonal antibody that targets the LGR4 receptor, an activator of Wnt signaling

Category: GM-CSF

Host: CHO cells

Isotype: Humanized IgG1

Species Reactivities: Human

Immunogen Sequence: FALSE

Accession #: Q9BXB1

Gene ID: 55366

Appearance: Liquid

Form: Humanized IgG1

Concentration:

Formulation: In PBS, pH 7.5

Purification: FALSE

Application: FALSE

Positive Control:

Application And Usages:

Country of Animal Origin: USA

Country of Manufacture: USA

Usage: For Research Use Only! Not to be used in humans.

Handling: The antibody solution should be gently mixed before use.

Western Blot Verified: FALSE

Immunocytochemistry Verified:

Immunofluorescence Verified: FALSE

Immunoprecipitation Verified: FALSE

FACS Verified:

ELISA Verified: FALSE

ChIP Verified: FALSE

Dot Blot Verified: FALSE

Flow Cytometry Verified: FALSE